Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Avai Bio (AVAI) Return on Capital Employed (2019 - 2023)

Avai Bio's Return on Capital Employed history spans 4 years, with the latest figure at 0.89% for Q4 2023.

  • For Q4 2023, Return on Capital Employed rose 37.0% year-over-year to 0.89%; the TTM value through Dec 2023 reached 0.89%, up 37.0%, while the annual FY2020 figure was 0.26%, N/A changed from the prior year.
  • Return on Capital Employed for Q4 2023 was 0.89% at Avai Bio, down from 0.35% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 13.78% in Q2 2020 and bottomed at 1.79% in Q2 2022.
  • The 4-year median for Return on Capital Employed is 0.03% (2023), against an average of 1.17%.
  • The largest annual shift saw Return on Capital Employed crashed -46bps in 2020 before it surged 176bps in 2023.
  • A 4-year view of Return on Capital Employed shows it stood at 0.3% in 2019, then crashed by -155bps to 0.16% in 2020, then crashed by -670bps to 1.25% in 2022, then grew by 29bps to 0.89% in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Return on Capital Employed are 0.89% (Q4 2023), 0.35% (Q3 2023), and 0.03% (Q2 2023).